Barclays views Illumina’s (ILMN) guidance last night as largely as expected. The bulls are going to defend the stock on China being de-risked, but Barclays still see risk with National ...

In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price target of $128.00. The company’s shares closed ...

Enabled on Illumina sequencers and a new multimodal analysis platform, Illumina's spatial technology delivers unbiased whole-transcriptome profiling with cellular resolution and high sensitivity.

Illumina and next-gen sequencing (NGS) are synonymous. But to anyone paying attention, the company’s recent emphasis on multiomics has been hard to miss. Indeed, the company has launched both ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers explore cellular behavior mapped across complex tissues. The announcement ...

(RTTNews) - Illumina, Inc. (ILMN) responded on Monday to the notice from the China Ministry of Commerce stating that it is not permitted to export sequencing instruments into China. Illumina said ...

The stock's rise snapped a four-day losing streak.

In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other large-cap stocks. The big and large-cap stocks have spearheaded the rally in the past ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against other top AI stocks buzzing on latest news. Investors are continuing to assess the impact of new ...